Skip to content

Achillestendinopathy Treated With Proximal Medial Gastrocnemius Recession

Proximal Medial Gastrocnemius Recession for Chronic Mid-Portion Achilles Tendinopathy; A Multicenter, Prospective Cohort Study.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05179551
Enrollment
60
Registered
2022-01-05
Start date
2021-12-31
Completion date
2025-12-31
Last updated
2024-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achilles Tendinopathy, Chronic Pain

Brief summary

This is a prospective cohort study that will follow 60 patients treated with Proximal Medial Gastrocnemius Recession for Chronic Mid-Portion Achilles Tendinopathy for 5 years postoperatively.

Detailed description

Mid Portion Achilles Tendinopathy is a condition that usually resolves by itself without any kind of intervention. If the condition becomes chronic, eccentric training guided by a physical therapist seems to be the best non-surgical intervention. Surgical treatment has shown varying results and no gold-standard exists. Tightness in the gastrocnemius muscle seems to be a contributing factor for many conditions in the foot and ankle region. Retrospective material suggest that Proximal Medial Gastrocnemius Recession (PMGR) can be an effective treatment for this condition. No prospective material exists. This study aims at including 60 patients with Chronic Mid-Portion Achilles Tendinopathy (CMPAT) that is non-responsive to eccentric training. Patients will be PMGR-surgery and followed for 5 years with PROMS, muscle function test and MRI scans.

Interventions

. A 3-4 cm transverse skin incision is made in the popliteal fossa, the superficial fascia is opened, and the medial gastrocnemius with its tendon (aponeurosis) is located. The tendon is then cut while lifting it with clamps, and care is taken to cut only the white tendon while sparing the underlying muscle. While performing a dorsiflexion movement of the ankle, careful palpation of the muscle is done to ensure that all tendon strands are cut completely. The incision is closed in layers, and only soft dressings applied

Sponsors

Oslo University Hospital
CollaboratorOTHER
Ostfold Hospital Trust
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Prospective Cohort Study

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Age 18-75 years. 2. Diagnosis CMPAT verified clinically by orthopedic surgeon. Symptoms must include mid-portion pain in the Achilles, swelling and reduced tolerance for weightbearing. 3. Verified diagnosis with MRI findings representing pathologic processes of tendon degeneration and repair (13). MRI no older than 12 months. 4. Duration of symptoms must be at least 12 months. 5. Isolated gastrocnemius tightness must be verified with the Silfverskiölds test before inclusion. The Silfverskiöld test is considered positive if ankle dorsiflexion is restricted to 5 degrees or less with the knee extended, and there is an increase of ankle dorsiflexion of at least 10 degrees when flexing the knee. 6. At least three months of conventional physical therapy with eccentric training must have been tried without providing relief of symptoms.

Exclusion criteria

1. Previous history of complete Achilles tendon rupture. 2. Other combined pathologies in the Achilles tendon of calf (Sequela from trauma, infections, cancer etc.). 3. Insertional Achilles tendinopathy. 4. Previously undergone surgery in affected tendon. 5. Patients with severe talocrural pathology or serious malalignment of foot and ankle. 6. Severely reduced peripheral circulation. 7. History of alcoholism, drug abuse, psychological or other emotional problems likely to jeopardize informed consent. 8. Patients with a contraindication/non-compliance for MRI examination. 9. History of allergic reaction/anaphylactic reaction to local anesthetics. 10. Not able to read and/or speak a Scandinavian language or English adequately. 11. Other serious comorbidity that makes surgery unadvisable.

Design outcomes

Primary

MeasureTime frameDescription
VISA-A - Victorian Institute of Sport Assessment- Achilles QuestionnaireBaselineA PROM validated for patients with achilles tendon disorders

Secondary

MeasureTime frameDescription
Achilles Function Test batteryBaseline, 3 months, 2 yearsThe test battery consists of three jump tests, a counter movements jump (CMJ), a drop counter movement jump (drop CMJ) and hopping, and two strength tests, concentric toe-raises, eccentric-concentric toe-raises and toe-raises for endurance. All recorded through the MuscleLab software.
Ankle Dorsiflexion pre and postoperativelyBaseline, 3 months, 2 yearsmeasured with a validated goniometer that measures the ankle's range of motion- The device has been previously tested and found to be valid, reliable, and responsive in detecting isolated gastrocnemius contractures (IGCs). An electric goniometer, Biometrics SG150 (Units 25-26, Biometrics Ltd, Newport, UK), with an accuracy of ±2 degrees and a repeatability of 1 degree will be used. The device will be calibrated before every new participant. Force applied directly beneath the head of the second metatarsal until the end range of dorsiflexion with a dynamometer.
MRI findings pre inclusion versus after 2 years.Baseline, 2yearsa. Tendon thickness - Thickest point anterior-posteriorly in the sagittal plane in millimeters. Cm2 at thickest point in the axial plane.
VASBaseline, 3 months, 1 year, 2 years, 5 yearsVisual Analogue Scale for pain during use of affected leg in the last 24 hours. 0 is no pain. 10 is worst pain imaginable.
Eq-5DBaseline, 3 months, 1 year, 2 years, 5 yearsQuality of life is measured by the EuroQol questionnaire (EQ-5D). EQ-5D is a validated generic health-related quality-of-life instrument. It consists of two parts: EQ-5D descriptive part and EQ-5D visual analogue scale. The descriptive part includes five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each with five possible answers (no problems, some problems, and major problems). EQ5D VAS is a visual analogue scale of self-related overall health, ranging from 0 (worst imaginable health state) to 100 (best imaginable health state).
Adverse eventsBaseline, 3 months, 1 year, 2 years, 5 yearsInfection, thrombosis, nerve injury etc
Assessment of treatment success - physical activity2 yearsLikert question: Achilles pain prevents me from performing physical activites 1\) Strongly Disagree; (2) Disagree; (3) Neither Agree nor Disagree; (4) Agree; (5) Strongly Agree
Assessment of treatment success - daily living2 yearsLikert question: Achilles pain prevents me from performing activities of daily living 1\) Strongly Disagree; (2) Disagree; (3) Neither Agree nor Disagree; (4) Agree; (5) Strongly Agree
Assessment of treatment success - calf pain2 yearsLikert question: I have pain and/or discomfort in the calf muscle that was operated two years ago 1\) Strongly Disagree; (2) Disagree; (3) Neither Agree nor Disagree; (4) Agree; (5) Strongly Agree
Assessment of treatment success - other treatments2 yearsI have received other treatments for achilles pain since surgery was preformed two years ago YES/NO
Assessment of treatment success - Patient Acceptable Symptom State2 yearsIf you were to continue having the same level of achilles symptoms in the coming few months, would you consider that acceptable? YES/NO
Assessment of treatment success - pain2 yearsLikert question: I have pain in the achilles tendon of the leg that was operated two years ago. 1\) Strongly Disagree; (2) Disagree; (3) Neither Agree nor Disagree; (4) Agree; (5) Strongly Agree

Countries

Norway

Contacts

Primary ContactMartin O Riiser, MD
riiser.martin@gmail.com+4797146230
Backup ContactMarius Molund, MD PhD
mariusmolund@hotmail.com+4790003099

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026